Validation of Turkish version of the Scleroderma Health Assessment Questionnaire

被引:19
|
作者
Karadag, Duygu Temiz [1 ]
Karakas, Fatih [2 ]
Tekeoglu, Senem [1 ]
Yazici, Ayten [1 ]
Isik, Ozlem Ozdemir [1 ]
Cefle, Ayse [1 ]
机构
[1] Kocaeli Univ, Sch Med, Dept Rheumatol, TR-41380 Kocaeli, Turkey
[2] Kocaeli Univ, Sch Med, TR-41380 Kocaeli, Turkey
关键词
Scleroderma Health Assessment Questionnaire Disability Index; Systemic sclerosis; Turkish; Validation; CROSS-CULTURAL ADAPTATION; QUALITY-OF-LIFE; SYSTEMIC-SCLEROSIS; DISABILITY INDEX; CLASSIFICATION; HYPERTENSION; VALIDITY; TRIALS;
D O I
10.1007/s10067-019-04494-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesThe Scleroderma Health Assessment Questionnaire (SHAQ) is a functional scale which consists of five scleroderma-specific items (overall disease severity, Raynaud's phenomenon, digital ulcers, respiratory and intestinal involvement) in addition to Health Assessment Questionnaire Disability Index (HAQ-DI). The objective of this study was to perform an adaptation and validation of a Turkish version of the SHAQ.MethodWe validated psychometric properties of the scale with 70 consecutive systemic sclerosis (SSc) patients, who fulfilled the 2013 ACR/EULAR classification criteria for SSc. We evaluated test-retest reliability with the intraclass correlation coefficient (ICC), discriminant validity by stratifying patients according to organ involvements and disease subtypes, and convergent validity by testing the correlation between SHAQ and related components of Short Form 36 version 2 (SF-36v2). Internal consistency of the questionnaire was evaluated by Cronbach's alpha coefficient.ResultsThe SHAQ-global, visual analogue scales (VAS) of pulmonary, digital ulcer, and Raynaud's phenomenon were significantly correlated with the physical component score of the SF-36v2 (r=-0.274, r=-0.295, r=-0.326, r=-0.308, p<0.05, respectively) for the convergent validity. The instruments could not discriminate between disease subtypes, except the digital ulcer VAS which was significantly higher in patients with dcSSc (1.000.93 vs 0.55 +/- 0.88, p=0.026) for the discriminant validity. The HAQ-DI, SHAQ-global, digital ulcer VAS, and pulmonary VAS showed moderate correlation with an increase in the number of the organs involved (r=0.319, r=0.329, r=0.341, r=0.278, p<0.05, respectively). We demonstrated high reproducibility for HAQ-DI (ICC=0.962, 95% confidence interval=0.934-0.978) and the other items of SHAQ. The overall internal consistency of the SHAQ was satisfactory (Cronbach's alpha=0.953).Conclusions The Turkish version of the SHAQ met the requirements of validity and reproducibility.
引用
收藏
页码:1917 / 1923
页数:7
相关论文
共 50 条
  • [1] Validation of Turkish version of the Scleroderma Health Assessment Questionnaire
    Duygu Temiz Karadag
    Fatih Karakas
    Senem Tekeoglu
    Ayten Yazici
    Ozlem Ozdemir Isik
    Ayse Cefle
    Clinical Rheumatology, 2019, 38 : 1917 - 1923
  • [2] Validation of a Romanian version of the scleroderma health assessment questionnaire
    Mihai, C.
    Ionescu, R.
    Rednic, S.
    Udrea, G.
    Burz, L.
    Chircu, J.
    Taranu, M.
    Suteanu, S.
    Stoica, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 516 - 516
  • [3] Translation and Validation of Indonesian Version of Scleroderma Health Assessment Questionnaire
    Defi, Irma Ruslina
    Jennie
    Vitriana
    Arisanti, Farida
    MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL, 2020, 52 (01): : 45 - 52
  • [4] Validation of french version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)
    Georges, C
    Chassany, O
    Mouthon, L
    Tiev, K
    Toledano, C
    Meyer, O
    Marjanovic, Z
    Heneggar, C
    Papo, T
    Crickx, B
    Sereni, D
    Cabane, J
    Farge, D
    CLINICAL RHEUMATOLOGY, 2005, 24 (01) : 3 - 10
  • [5] Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)
    C. Georges
    O. Chassany
    L. Mouthon
    K. Tiev
    C. Toledano
    O. Meyer
    Z. Marjanovic
    C. Heneggar
    T. Papo
    B. Crickx
    D. Sereni
    J. Cabane
    D. Farge
    Clinical Rheumatology, 2005, 24 : 3 - 10
  • [6] Translation and validation of the Persian version of the scleroderma health assessment questionnaire (SHAQ)
    Sepehr Nayebirad
    Alireza Emamzade
    Mojtaba Sedaghat
    Ali Montazeri
    Farhad Gharibdoost
    Mehdi Yaseri
    Zahra Tamartash
    Samira Salehi
    Toktam Kiani
    Samaneh Soltani
    Amirmohammad Mohammadzadegan
    Amirhosseyn eshaghi
    Mohammad Reza Madanipour
    Reza Atef Yekta
    Hoda Kavosi
    Internal and Emergency Medicine, 2023, 18 : 811 - 819
  • [7] Translation and validation of the Persian version of the scleroderma health assessment questionnaire (SHAQ)
    Nayebirad, Sepehr
    Emamzade, Alireza
    Sedaghat, Mojtaba
    Montazeri, Ali
    Gharibdoost, Farhad
    Yaseri, Mehdi
    Tamartash, Zahra
    Salehi, Samira
    Kiani, Toktam
    Soltani, Samaneh
    Mohammadzadegan, Amirmohammad
    Eshaghi, Amirhosseyn
    Madanipour, Mohammad Reza
    Atef Yekta, Reza
    Kavosi, Hoda
    INTERNAL AND EMERGENCY MEDICINE, 2023, 18 (03) : 811 - 819
  • [8] THE VALIDATION OF THE SCLERODERMA HEALTH ASSESSMENT QUESTIONNAIRE IN TURKISH SPEAKING PATIENTS WITH SYSTEMIC SCLEROSIS
    Karadag, D. Temiz
    Karakas, F.
    Tekeoglu, S.
    Isik, O. Ozdemir
    Yazici, A.
    Cefle, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 634 - 634
  • [9] Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ)
    Rocha, Luiza F.
    Marangoni, Roberta G.
    Sampaio-Barros, Percival D.
    Levy-Neto, Mauricio
    Yoshinari, Natalino H.
    Bonfa, Eloisa
    Steen, Virginia
    Kowalski, Sergio C.
    CLINICAL RHEUMATOLOGY, 2014, 33 (05) : 699 - 706
  • [10] Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ)
    Luiza F. Rocha
    Roberta G. Marangoni
    Percival D. Sampaio-Barros
    Mauricio Levy-Neto
    Natalino H. Yoshinari
    Eloisa Bonfa
    Virginia Steen
    Sergio C. Kowalski
    Clinical Rheumatology, 2014, 33 : 699 - 706